Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lian Wang"'
Autor:
Xudong Shi, Lian-Wang Guo, Bowen Wang, Mengxue Zhang, Toshio Takayama, K. Craig Kent, Drew Alan Roenneburg
Publikováno v:
EBioMedicine, Vol 2, Iss 11, Pp 1650-1661 (2015)
EBioMedicine
EBioMedicine
Background Intimal hyperplasia is a common cause of many vasculopathies. There has been a recent surge of interest in the bromo and extra-terminal (BET) epigenetic “readers” including BRD4 since the serendipitous discovery of JQ1(+), an inhibitor
Autor:
Ming-Liang Chu, Lian-Wang Guo, Huan Yang, Christopher R. McCurdy, Arnold E. Ruoho, Uyen B. Chu, Amanda Schulman, Christophe Mesangeau, Timur A. Mavlyutov
Publikováno v:
EBioMedicine, Vol 2, Iss 11, Pp 1806-1813 (2015)
EBioMedicine
EBioMedicine
The sigma-2 receptor (S2R) is a potential therapeutic target for cancer and neuronal diseases. However, the identity of the S2R has remained a matter of debate. Historically, the S2R has been defined as (1) a binding site with high affinity to 1,3-di
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bowen Wang, Mengxue Zhang, Toshio Takayama, Xudong Shi, Drew Alan Roenneburg, K. Craig Kent, Lian-Wang Guo
Publikováno v:
EBioMedicine, Vol 2, Iss 11, Pp 1650-1661 (2015)
Background: Intimal hyperplasia is a common cause of many vasculopathies. There has been a recent surge of interest in the bromo and extra-terminal (BET) epigenetic “readers” including BRD4 since the serendipitous discovery of JQ1(+), an inhibito
Externí odkaz:
https://doaj.org/article/40cfbd0e3dd045c5a02d3175b5840ec1
Autor:
Uyen B. Chu, Timur A. Mavlyutov, Ming-Liang Chu, Huan Yang, Amanda Schulman, Christophe Mesangeau, Christopher R. McCurdy, Lian-Wang Guo, Arnold E. Ruoho
Publikováno v:
EBioMedicine, Vol 2, Iss 11, Pp 1806-1813 (2015)
The sigma-2 receptor (S2R) is a potential therapeutic target for cancer and neuronal diseases. However, the identity of the S2R has remained a matter of debate. Historically, the S2R has been defined as (1) a binding site with high affinity to 1,3-di
Externí odkaz:
https://doaj.org/article/a59889769470463ca1fb2549fc5cc67d